| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,440 | 20,551 | 18,238 | 18,577 | | Cost of Revenue | 3,145 | 6,117 | 5,735 | 8,020 | | | Gross Profit | 6,295 | 14,434 | 12,502 | 10,557 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,916 | 4,015 | 3,131 | 5,676 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,379 | 10,419 | 9,372 | 4,881 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 60 | 73 | 40 | (553) | | Earnings Before Interest And Taxes | 3,439 | 10,492 | 9,412 | 4,328 | | Interest Expense | 40 | 53 | 53 | 66 | | Income Before Tax | 3,399 | 10,438 | 9,359 | 4,262 | | Income Tax Expense | 545 | 123 | 360 | (952) | | Minority Interest | (618) | (139) | (407) | (336) | | | | Net Income From Continuing Ops | 2,236 | 10,176 | 8,593 | 4,878 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,236 | 10,176 | 8,593 | 4,878 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,236 | $10,176 | $8,593 | $4,878 |
|
0.57% Nasdaq 
0.09%
Income Statement
